Chris O'Brien, based in Philadelphia, PA, US, is currently a Chief Medical Officer at Kinaset Therapeutics, bringing experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Teva Pharmaceuticals. Chris O'Brien holds a 1997 - 2002 PhD in Cell/Cellular and Molecular Biology @ University of Pennsylvania School of Medicine. With a robust skill set that includes Development, Clinical Trials, Sales, Pulmonology, Clinical Research and more, Chris O'Brien contributes valuable insights to the industry. Chris O'Brien has 4 emails and 1 mobile phone number on RocketReach.